BioSpace News Archive

Immunicum AB (Publ) Initiates Trading of Shares on Nasdaq Stockholm

Immunicum is listed as a small cap company within the healthcare sector.

January 15, 2018
·
1 min read
Policy

Shire Granted EU Marketing Authorization for ADYNOVI [Antihemophilic Factor (Recombinant), Pegylated] for Adults and Adolescents With Hemophilia A

Marketing Authorization will enable patient access to ADYNOVI throughout Europe.

January 15, 2018
·
13 min read
Genetown

GI Dynamics, Inc. Provides 2017 Review and 2018 Business Outlook

GI Dynamics is preparing to submit an Investigational Device Exemption (IDE1) application to the US Food and Drug Administration (FDA) for a new pivotal trial of the EndoBarrier.

January 15, 2018
·
12 min read
Tigenix: Transparency Notifications Pursuant to Article 14 of the Law of May 2, 2007

It concerns the following four notifications:

January 15, 2018
·
8 min read
Business

Supernus Mourns the Loss of Board Member William Nuerge

Mr. Nuerge had a long and distinguished career in the pharmaceutical industry, including serving as CEO of Shire US and Xanodyne Pharmaceuticals until his retirement.

January 15, 2018
·
1 min read
Biotech Bay

Dynavax Technologies Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

Dynavax granted stock options to purchase shares of Dynavax’s common stock to the new employees with an exercise price of $16.85 per share.

January 15, 2018
·
1 min read
Novo Nordisk A/S - Share Repurchase Programme - Jan. 15, 2018

Under the programme initiated 1 November 2017, Novo Nordisk will repurchase B shares for an amount up to DKK 4.8 billion in the period from 1 November 2017 to 30 January 2018.

January 15, 2018
·
1 min read
Business

Mauna Kea Technologies Appoints Experienced Healthcare Executive, Molly O’Neill, to Board of Directors

Mauna Kea Technologies today announced the appointment of Molly O’Neill to the Company’s Board of Directors, effective immediately.

January 15, 2018
·
4 min read
Zealand Pharma Major Shareholder Announcement: Royce & Associates, LLC, U.S.

Their holding following the decrease amounts to 4.99% or 1,534,556 shares.

January 15, 2018
·
1 min read
Biotech Beach

Charles Laverty Announces Major Expansion Plans at Advanced Bifurcation Systems

The company has developed a novel technology to overcome limitations in the current approach to bifurcation lesions in coronary angioplasties.

January 15, 2018
·
2 min read